Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
A trio of companies have announced the cancellation of contracts to deliver work on the Trojena ski resort and The Line city as the Neom project in Saudi Arabia stalls. Steel company Eversendai ...
According to a superseding indictment unsealed in January 2024 by the U.S. Attorney's Office for the Eastern District of New ...
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...
The investment seeks long-term total return. The fund will seek to achieve its investment objective by investing principally in a portfolio of residential and commercial mortgage-backed securities and ...
Kesimpta is a prescription medication used to treat clinically isolated syndrome (CIS) and relapsing forms of multiple sclerosis (MS). Kesimpta comes as a solution inside single-dose prefilled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results